Received Feb 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
had some injection site pain for a few days but no other problems.; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. Family history included shingles. On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and Shingrix, the patient experienced injection site pain (Verbatim: had some injection site pain for a few days but no other problems.). The outcome of the injection site pain was resolved. It was unknown if the reporter considered the injection site pain to be related to Shingrix and Shingrix. It was unknown if the company considered the injection site pain to be related to Shingrix and Shingrix. Additional Information: GSK Receipt Date: 17-FEB-2025 This case was reported by a patient via interactive digital media. The patient got the two part Shingrix vaccine last year (2024) and had some injection site pain for a few days but no other problems. The patient saw his/her father go through several bouts of shingles.
Medical History/Concurrent Conditions: Shingles